Story perspectives

Zimmer Biomet Acquires Monogram for $177 Million to Boost Robotics

7/15/2025

40 3

Summary

Story summary

Zimmer Biomet is set to acquire Monogram Technologies for about $177 million, at $4.04 per share.
Monogram's FDA-cleared mBôS robot provides AI navigation for knee replacements, launching with Zimmer implants in 2027.
This acquisition will strengthen Zimmer's robotics portfolio, aiming for leadership in autonomous surgical robots.
Monogram shareholders could earn extra payments based on future milestones, with the deal closing later this year.
Zimmer expects revenue growth from the acquisition in 2027, initially neutral on earnings per share.

1 of 1

Story summary

Zimmer Biomet is set to acquire Monogram Technologies for about $177 million, at $4.04 per share.
Monogram's FDA-cleared mBôS robot provides AI navigation for knee replacements, launching with Zimmer implants in 2027.
This acquisition will strengthen Zimmer's robotics portfolio, aiming for leadership in autonomous surgical robots.
Monogram shareholders could earn extra payments based on future milestones, with the deal closing later this year.
Zimmer expects revenue growth from the acquisition in 2027, initially neutral on earnings per share.